Financial Comparison: NewGenIvf Group (NASDAQ:NIVF) & Sotera Health (NASDAQ:SHC)

Sotera Health (NASDAQ:SHC) and NewGenIvf Group (NASDAQ:NIVF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, earnings, institutional ownership, risk, analyst recommendations and valuation.

Institutional and Insider Ownership

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 55.1% of Sotera Health shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Sotera Health has a beta of 2.08, suggesting that its share price is 108% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500.

Profitability

This table compares Sotera Health and NewGenIvf Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sotera Health	6.31%	42.27%	6.02%
NewGenIvf Group	N/A	N/A	N/A

Earnings and Valuation

This table compares Sotera Health and NewGenIvf Group”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.05 billion	3.86	$51.38 million	$0.25	57.24
NewGenIvf Group	$5.14 million	0.47	$130,000.00	N/A	N/A

Sotera Health has higher revenue and earnings than NewGenIvf Group.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Sotera Health and NewGenIvf Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0	2	4	0	2.67
NewGenIvf Group	0	0	0	0	0.00

Sotera Health presently has a consensus price target of $16.50, suggesting a potential upside of 15.30%. Given Sotera Health’s stronger consensus rating and higher probable upside, research analysts clearly believe Sotera Health is more favorable than NewGenIvf Group.

Summary

Sotera Health beats NewGenIvf Group on 12 of the 12 factors compared between the two stocks.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

About NewGenIvf Group

A SPAC I Acquisition Corp. is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. A SPAC I Acquisition Corp. is based in Singapore.